Clinical Trials Browser

Phase 4 × OTHER × Cyclooxygenase 2 Inhibitors × Clear all

NCT01111591 2016-10-28

Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer

Phase 4 Unknown

Gastrointestinal

Bile Duct Neoplasms, Pancreatic Neoplasms